GLA
NVO

Great Lakes Advisors’s Novo Nordisk NVO Stock Holding History

Great Lakes Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,681
Closed -$317K – 846
2024
Q4 		$317K Sell
3,681
-20
-0.5% -$2.16K ﹤0.01% 716
2024
Q3 		$441K Buy
3,701
+15
+0.4% +$2K ﹤0.01% 671
2024
Q2 		$526K Buy
3,686
+52
+1% +$6.89K ﹤0.01% 647
2024
Q1 		$467K Hold
3,634
– – ﹤0.01% 627
2023
Q4 		$376K Sell
3,634
-420
-10% -$41.5K ﹤0.01% 648
2023
Q3 		$369K Buy
4,054
+402
+11% +$35.4K ﹤0.01% 635
2023
Q2 		$296K Sell
3,652
-2
-0.1% -$163 ﹤0.01% 646
2023
Q1 		$291K Hold
3,654
– – ﹤0.01% 715
2022
Q4 		$247K Buy
+3,654
New +$214K 0.01% 589
2022
Q3 		– Sell
-4,406
Closed -$245K – 687
2022
Q2 		$245K Buy
4,406
+34
+0.8% +$1.89K ﹤0.01% 604
2022
Q1 		$243K Buy
4,372
+282
+7% +$14.5K ﹤0.01% 642
2021
Q4 		$229K Buy
+4,090
New +$222K ﹤0.01% 642

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Great Lakes Advisors's NVO Position: Q1 2025 in Review

Great Lakes Advisors sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 3,681 shares — an estimated $317K sold.

Great Lakes Advisors first reported a position in NVO in Q4 2021 and held it in 12 quarters. The position peaked at $526K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Great Lakes Advisors reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Great Lakes Advisors sold 3,681 Novo Nordisk shares in Q1 2025, an estimated $317K.
  • Great Lakes Advisors first reported a position in Novo Nordisk in Q4 2021 and held it in 12 quarters.
  • Great Lakes Advisors's Novo Nordisk position peaked at $526K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Great Lakes Advisors's 13F filing for Q1 2025, filed 16 May 2025.